NASDAQ$OMCL
Omnicell Inc. · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Announced strong financial results with GAAP and non-GAAP revenues of $319 million, and launched innovative IVX Station robotic compounding technology.
Omnicell reported a strong start to 2022 with GAAP and non-GAAP revenues of $319 million. The company's GAAP net income per diluted share was $0.17, while non-GAAP net income per diluted share was $0.83. Omnicell also launched IVX Station, an innovative robotic compounding technology.
- Total GAAP revenues for the first quarter of 2022 were $319 million, up 27% from the first quarter of 2021.
- GAAP net income for the first quarter of 2022 was $8 million, or $0.17 per diluted share.
- Total non-GAAP revenues for the first quarter of 2022 were $319 million, up 27% from the first quarter of 2021.
- Non-GAAP net income for the first quarter of 2022 was $38 million, or $0.83 per diluted share.
Headline financials
Revenue & EPS history
Omnicell · Revenue · Quarterly
$319M
Revenue by segment
Omnicell · $226M total across 1 segment · Q1 2022
- Product revenues$226M+26.8%100.0%
Forward guidance
For the full year 2022, the Company expects total GAAP and non-GAAP revenues to be between $1.385 billion and $1.410 billion. For the second quarter of 2022, the Company expects total GAAP and non-GAAP revenues to be between $337 million and $343 million.
Tailwinds
- Full year 2022 product bookings are expected to be between $1.370 billion and $1.430 billion.
- Full year 2022 total GAAP and non-GAAP revenues are expected to be between $1.385 billion and $1.410 billion.
- Full year 2022 GAAP and non-GAAP product revenues are expected to be between $975 million and $990 million.
- Full year 2022 GAAP and non-GAAP service revenues are expected to be between $410 million and $420 million.
- Full year 2022 non-GAAP EBITDA is expected to be between $243 million and $255 million.
Headwinds
- Second quarter 2022 total GAAP and non-GAAP revenues are expected to be between $337 million and $343 million.
- Second quarter 2022 GAAP and non-GAAP product revenues are expected to be between $241 million and $244 million.
- Second quarter 2022 GAAP and non-GAAP service revenues are expected to be between $96 million and $99 million.
- Second quarter 2022 non-GAAP EBITDA is expected to be between $54 million and $58 million.
- Second quarter 2022 non-GAAP earnings are expected to be between $0.82 and $0.89 per share.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
+0.7%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+4.7%
Avg return
30 days after
55%
36 / 65 earnings
Positive
+34.3%
Q2 2024
Best reaction
-29.4%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +13.7% | +18.8% | |
| Q4 2025 | -16.3% | -16.5% | -11.5% | |
| Q3 2025 | +13.4% | +16.7% | +23.5% | |
| Q1 2025 | -16.0% | -15.4% | +1.2% | |
| Q4 2024 | -11.2% | -7.1% | -16.7% | |
| Q3 2024 | +21.2% | +20.9% | +16.1% | |
| Q2 2024 | +34.3% | +41.6% | +52.3% | |
| Q1 2024 | +10.9% | +11.5% | +19.9% | |
| Q4 2023 | -15.6% | -11.9% | -12.0% | |
| Q3 2023 | -14.9% | -13.9% | -5.5% | |
| Q2 2023 | +2.3% | +2.9% | -10.0% | |
| Q1 2023 | +8.9% | +7.1% | +18.6% | |
| Q4 2022 | +7.9% | +6.6% | +6.4% | |
| Q3 2022 | -29.4% | -35.9% | -33.4% | |
| Q2 2022 | -2.1% | -5.6% | -10.6% | |
| Q1 2022 | +1.2% | +5.9% | +4.7% | |
| Q4 2021 | -9.6% | -18.4% | -11.5% | |
| Q3 2021 | +2.2% | +1.6% | +1.5% | |
| Q2 2021 | -1.1% | +0.4% | +7.1% | |
| Q1 2021 | +1.8% | -1.5% | -2.4% | |
| Q4 2020 | +7.0% | +8.9% | +6.5% | |
| Q3 2020 | +2.3% | +2.9% | +27.0% | |
| Q2 2020 | +9.1% | +5.5% | +2.7% | |
| Q1 2020 | -6.1% | -12.3% | -0.5% | |
| Q4 2019 | -1.4% | +2.3% | -4.5% | |
| Q3 2019 | -3.7% | -1.9% | +7.4% | |
| Q2 2019 | +6.7% | +5.4% | +0.6% | |
| Q1 2019 | +0.7% | +3.8% | +4.7% | |
| Q4 2018 | +17.9% | +21.0% | +28.0% | |
| Q3 2018 | +6.1% | +15.2% | +18.8% | |
| Q2 2018 | +13.7% | +13.0% | +29.5% | |
| Q1 2018 | +1.6% | -0.1% | +5.3% | |
| Q4 2017 | -6.2% | -9.8% | -12.9% | |
| Q3 2017 | -6.4% | -8.2% | -7.6% | |
| Q2 2017 | +12.5% | +16.3% | +12.1% | |
| Q1 2017 | -3.2% | -1.7% | +0.0% | |
| Q4 2016 | -0.7% | +1.0% | +4.5% | |
| Q3 2016 | -6.3% | -6.8% | +3.2% | |
| Q2 2016 | +6.8% | +4.7% | +3.4% | |
| Q1 2016 | +3.9% | — | — | |
| Q4 2015 | -1.0% | — | — | |
| Q3 2015 | -10.5% | — | — | |
| Q2 2015 | -8.8% | — | — | |
| Q1 2015 | -2.6% | — | — | |
| Q4 2014 | +5.3% | — | — | |
| Q3 2014 | +9.7% | — | — | |
| Q2 2014 | -3.9% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2013 | +8.9% | — | — | |
| Q3 2013 | -1.4% | — | — | |
| Q2 2013 | +8.7% | — | — | |
| Q1 2013 | +7.6% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q4 2012 | +13.4% | — | — | |
| Q3 2012 | +12.2% | — | — | |
| Q2 2012 | +0.9% | — | — | |
| Q1 2011 | -0.3% | — | — | |
| Q1 2012 | +4.8% | — | — | |
| Q4 2011 | +2.6% | — | — | |
| Q4 2009 | +2.6% | — | — | |
| Q3 2011 | -0.7% | — | — | |
| Q2 2010 | -16.9% | — | — | |
| Q2 2011 | -16.9% | — | — | |
| Q4 2010 | -16.9% | — | — | |
| Q1 2010 | +7.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro